Your browser doesn't support javascript.
loading
Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey.
Küçükdiler, Ayse Hilal Eroglu; Yavasoglu, Irfan; Selim, Cem; Mutlu, Cansu Atmaca; Karakus, Abdullah; Koyuncu, Mahmut Bakir; Bilgir, Oktay; Ayyildiz, Orhan; Tiftik, Eyüp Naci; Bolaman, Ali Zahit.
Afiliação
  • Küçükdiler AHE; Aydin Adnan Menderes University Faculty of Medicine, Department of Hematology, Turkey.
  • Yavasoglu I; Aydin Adnan Menderes University Faculty of Medicine, Department of Hematology, Turkey.
  • Selim C; Aydin Adnan Menderes University Faculty of Medicine, Department of Hematology, Turkey.
  • Mutlu CA; Izmir Bozyaka Training and Research Hospital, Department of Adult Hematology, Turkey.
  • Karakus A; Dicle University Faculty of Medicine, Department of Adult Hematology, Turkey.
  • Koyuncu MB; Mersin University Faculty of Medicine, Department of Adult Hematology, Turkey.
  • Bilgir O; Izmir Bozyaka Training and Research Hospital, Department of Adult Hematology, Turkey.
  • Ayyildiz O; Dicle University Faculty of Medicine, Department of Adult Hematology, Turkey.
  • Tiftik EN; Mersin University Faculty of Medicine, Department of Adult Hematology, Turkey.
  • Bolaman AZ; Aydin Adnan Menderes University Faculty of Medicine, Department of Hematology, Turkey.
Leuk Res Rep ; 16: 100280, 2021.
Article em En | MEDLINE | ID: mdl-34849337
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article